Denali Therapeutics Inc.DNLINASDAQ
Loading
Debt to Equity Over TimeNormalizing
Percentile Rank50
3Y CAGR-10.3%
5Y CAGR-7.0%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-10.3%/yr
Annual compound
5Y CAGR
-7.0%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.04 | +5.3% |
| 2024 | 0.04 | -21.8% |
| 2023 | 0.05 | -12.5% |
| 2022 | 0.06 | -13.0% |
| 2021 | 0.07 | +11.1% |
| 2020 | 0.06 | -67.4% |
| 2019 | 0.18 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |